{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:05:58Z","timestamp":1740135958725,"version":"3.37.3"},"reference-count":37,"publisher":"Medical Association of Nippon Medical School","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nippon Med Sch"],"published-print":{"date-parts":[[2024,6,25]]},"DOI":"10.1272\/jnms.jnms.2024_91-307","type":"journal-article","created":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T22:11:11Z","timestamp":1720131071000},"page":"285-295","source":"Crossref","is-referenced-by-count":0,"title":["Candesartan Attenuates Vasculitis in a Mouse Model of Kawasaki Disease Induced by <i>Candida albicans<\/i> Water-Soluble Fraction"],"prefix":"10.1272","volume":"91","author":[{"given":"Ryosuke","family":"Matsui","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuji","family":"Fukazawa","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryohei","family":"Fukunaga","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Motoji","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Kitasato University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiaki","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Nagi-Miura","sequence":"additional","affiliation":[{"name":"Center for the Advancement of Pharmaceutical Education, Tokyo University of Pharmacy and Life Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiko","family":"Itoh","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"21","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Fukazawa R, Kobayashi J, Ayusawa M, et al. JCS\/JSCS 2020 guideline on diagnosis and management of cardiovascular sequelae in Kawasaki disease. Circ J [Internet]. 2020 Jul 22;84 (8):1348-407. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32641591. PubMed PMID: 32641591","DOI":"10.1253\/circj.CJ-19-1094"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Yeo KK, Fukazawa R, Ayusawa M, et al. Asian Pacific Society of Cardiology consensus statement on management of coronary artery disease in adults with late complications of Kawasaki disease. J Asian Pac Soc Cardiol [Internet]. 2023;2:e34. Available from: http:\/\/dx.doi.org\/10.15420\/japsc.2022.30","DOI":"10.15420\/japsc.2022.30"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Fukazawa R, Ogawa S. Long-term prognosis of patients with Kawasaki disease: at risk for future atherosclerosis? J Nippon Med Sch [Internet]. 2009 Jun;76 (3):124-33. Available from: http:\/\/dx.doi.org\/JST.JSTAGE\/jnms\/76.124. PubMed PMID: 19602819","DOI":"10.1272\/jnms.76.124"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Furusho K, Sato K, Soeda T, et al. High-dose intravenous gammaglobulin for Kawasaki disease. Lancet. 1983 Dec 10;2 (8363):1359.","DOI":"10.1016\/S0140-6736(83)91109-1"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Newburger JW, Takahashi M, Beiser AS, et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med. 1991 Jun 6;324 (23):1633-9.","DOI":"10.1056\/NEJM199106063242305"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Ogata S, Ogihara Y, Honda T, Kon S, Akiyama K, Ishii M. Corticosteroid pulse combination therapy for refractory Kawasaki disease: a randomized trial. Pediatrics [Internet]. 2012 Jan;129 (1):e17-23. Available from: http:\/\/dx.doi.org\/10.1542\/peds.2011-0148","DOI":"10.1542\/peds.2011-0148"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kobayashi T, Saji T, Otani T, et al. Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial. Lancet [Internet]. 2012 Apr 28;379 (9826):1613-20. Available from: http:\/\/dx.doi.org\/10.1016\/S0140-6736(11)61930-2. PubMed PMID: 22405251","DOI":"10.1016\/S0140-6736(11)61930-2"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Masuda H, Abe J, Oana S, et al. Effects of Anti-TNF-alpha antibody therapy on IVIG-resistant patients with Kawasaki disease. Circulation [Internet]. 2015;131:AO51. Available from: https:\/\/www.ahajournals.org\/doi\/10.1161\/circ.131.suppl_2.o51","DOI":"10.1161\/circ.131.suppl_2.o51"},{"key":"9","unstructured":"9. [National Survey Group for Kawasaki Disease, Japan Kawasaki Disease Research Center]. [Results of the 26th National Survey of Kawasaki Disease] [Internet]. 2021 Sep. [cited 2023 Oct 24]. Available from: https:\/\/www.jichi.ac.jp\/dph\/wp-dph\/wp-content\/uploads\/2022\/04\/a19b047d4b9e6fbb84b6b187236779c8.pdf. Japanese."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Kobayashi T, Inoue Y, Takeuchi K, et al. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation. 2006 Jun 6;113 (22):2606-12.","DOI":"10.1161\/CIRCULATIONAHA.105.592865"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Sano T, Kurotobi S, Matsuzaki K, et al. Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment. Eur J Pediatr [Internet]. 2007 Feb;166 (2):131-7. Available from: http:\/\/dx.doi.org\/10.1007\/s00431-006-0223-z. PubMed PMID: 16896641","DOI":"10.1007\/s00431-006-0223-z"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Egami K, Muta H, Ishii M, et al. Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. J Pediatr [Internet]. 2006 Aug;149 (2):237-40. Available from: http:\/\/dx.doi.org\/10.1016\/j.jpeds.2006.03.050. PubMed PMID: 16887442","DOI":"10.1016\/j.jpeds.2006.03.050"},{"key":"13","unstructured":"13. Miura M, Ayusawa M, Fukazawa R, et al. Guidelines for Medical Treatment of Acute Kawasaki Disease (2020 Revised Version). J Pediatric Cardiol Cardiac Surg [Internet]. 2021;5 (1):41-73. Available from: http:\/\/dx.doi.org\/10.24509\/jpccs.0501G1"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Shah RV, Desai AS, Givertz MM. The effect of renin-angiotensin system inhibitors on mortality and heart failure hospitalization in patients with heart failure and preserved ejection fraction: a systematic review and meta-analysis. J Card Fail [Internet]. 2010 Mar;16 (3):260-7. Available from: https:\/\/doi.org\/10.1016\/j.cardfail.2009.11.007","DOI":"10.1016\/j.cardfail.2009.11.007"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Tervaert JW. Translational mini-review series on immunology of vascular disease: accelerated atherosclerosis in vasculitis. Clin Exp Immunol [Internet]. 2009 Jun;156 (3):377-85. Available from: http:\/\/dx.doi.org\/10.1111\/j.1365-2249.2009.03885.x. PubMed Central PMCID: PMC2691964","DOI":"10.1111\/j.1365-2249.2009.03885.x"},{"key":"16","unstructured":"16. Ogawa S, Fukazawa R, Kamisago M, et al. Angiotensin II type 1 receptor blockers inhibit significant coronary stenosis in patients with coronary aneurysm after Kawasaki disease. Circulation. 2004;110 (suppl):707."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Suganuma E, Niimura F, Matsuda S, et al. Losartan attenuates the coronary perivasculitis through its local and systemic anti-inflammatory properties in a murine model of Kawasaki disease. Pediatr Res [Internet]. 2017 Apr;81 (4):593-600. Available from: http:\/\/dx.doi.org\/10.1038\/pr.2016.266","DOI":"10.1038\/pr.2016.266"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Uchimura R, Ueda T, Fukazawa R, et al. Adipose tissue-derived stem cells suppress coronary arteritis of Kawasaki disease in vivo. Pediatr Int [Internet]. 2020 Jan;62 (1):14-21. Available from: http:\/\/dx.doi.org\/10.1111\/ped.14062. PubMed PMID: 31758839","DOI":"10.1111\/ped.14062"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Dutta S, Sengupta P. Men and mice: relating their ages. Life Sci [Internet]. 2016 May 1;152:244-8. Available from: http:\/\/dx.doi.org\/10.1016\/j.lfs.2015.10.025. PubMed PMID: 26596563","DOI":"10.1016\/j.lfs.2015.10.025"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Hashimoto Y, Fukazawa R, Nagi-Miura N, et al. Interleukin-1beta inhibition attenuates vasculitis in a mouse model of Kawasaki disease. J Nippon Med Sch [Internet]. 2019;86 (2):108-16. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31130561. PubMed PMID: 31130561","DOI":"10.1272\/jnms.JNMS.2019_86-206"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Motoji Y, Fukazawa R, Matsui R, et al. Kawasaki disease-like vasculitis facilitates atherosclerosis, and statin shows a significant antiatherosclerosis and anti-Inflammatory effect in a Kawasaki disease model mouse. Biomedicines [Internet]. 2022 Jul 26;10 (8):1794. Available from: http:\/\/dx.doi.org\/10.3390\/biomedicines10081794. PubMed Central PMCID: PMC9330289","DOI":"10.3390\/biomedicines10081794"},{"key":"22","unstructured":"22. Nagoya City Kidney Disease Study Group. NCKiDs Hypertension [Internet]. 2013 Jun. [cited 2023 Nov 17]. Available from: https:\/\/www.nagoya2.jrc.or.jp\/content\/uploads\/2016\/11\/kouketsuatsushou.pdf. Japanese."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Mantovani A, Biswas SK, Galdiero MR, Sica A, Locati M. Macrophage plasticity and polarization in tissue repair and remodelling. J Pathol [Internet]. 2013 Jan;229 (2):176-85. Available from: http:\/\/dx.doi.org\/10.1002\/path.4133. PubMed PMID: 23096265","DOI":"10.1002\/path.4133"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Batlle E, Massague J. Transforming growth factor-\u03b2 signaling in immunity and cancer. Immunity [Internet]. 2019 Apr 16;50 (4):924-40. Available from: http:\/\/dx.doi.org\/10.1016\/j.immuni.2019.03.024. PubMed Central PMCID: PMC7507121","DOI":"10.1016\/j.immuni.2019.03.024"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Lee AM, Shimizu C, Oharaseki T, et al. Role of TGF-\u03b2 signaling in remodeling of noncoronary artery aneurysms in Kawasaki disease. Pediatr Dev Pathol [Internet]. 2015 Jul-Aug;18 (4):310-7. Available from: http:\/\/dx.doi.org\/10.2350\/14-12-1588-OA.1. PubMed PMID: 25856633","DOI":"10.2350\/14-12-1588-OA.1"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Shimizu C, Oharaseki T, Takahashi K, Kottek A, Franco A, Burns JC. The role of TGF-\u03b2 and myofibroblasts in the arteritis of Kawasaki disease. Hum Pathol [Internet]. 2013 Feb;44 (2):189-98. Available from: http:\/\/dx.doi.org\/10.1016\/j.humpath.2012.05.004. PubMed Central PMCID: PMC3518690","DOI":"10.1016\/j.humpath.2012.05.004"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Shimizu C, Jain S, Davila S, et al. Transforming growth factor-beta signaling pathway in patients with Kawasaki disease. Circ Cardiovasc Genet [Internet]. 2011 Feb;4 (1):16-25. Available from: http:\/\/dx.doi.org\/10.1161\/circgenetics.110.940858. PubMed Central PMCID: 3073847","DOI":"10.1161\/CIRCGENETICS.110.940858"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Takahashi K, Oharaseki T, Yokouchi Y, et al. Administration of human immunoglobulin suppresses development of murine systemic vasculitis induced with Candida albicans water-soluble fraction: an animal model of Kawasaki disease. Mod Rheumatol [Internet]. 2010 Apr;20 (2):160-7. Available from: http:\/\/dx.doi.org\/10.1007\/s10165-009-0250-5","DOI":"10.1007\/s10165-009-0250-5"},{"key":"29","unstructured":"29. Kim S, Iwao H. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev. 2000 Mar;52 (1):11-34."},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. McKelvie RS, Yusuf S, Pericak D, et al. Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators. Circulation [Internet]. 1999 Sep 7;100 (10):1056-64. Available from: http:\/\/www.circulationaha.org\/cgi\/content\/full\/100\/10\/1056","DOI":"10.1161\/01.CIR.100.10.1056"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Heart Outcomes Prevention Evaluation Study Investigators; Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an Angiotensin-Converting-Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients. N Engl J Med [Internet]. 2000 Jan 20;342 (3):145-53. Available from: http:\/\/content.nejm.org\/cgi\/content\/abstract\/342\/3\/145","DOI":"10.1056\/NEJM200001203420301"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Yusuf S, Pfeffer MA, Swedberg K, et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet [Internet]. 2003 Sep 6;362 (9386):777-81. Available from: http:\/\/dx.doi.org\/S0140-6736(03)14285-7. PubMed PMID: 13678871","DOI":"10.1016\/S0140-6736(03)14285-7"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med. 1996 May 23;334 (21):1349-55.","DOI":"10.1056\/NEJM199605233342101"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Gan Y, Feng Y, Zhou X, et al. Serum levels of angiotensin-converting enzyme 2 in children with Kawasaki disease. Clin Exp Med [Internet]. 2023 Aug;23 (4):1325-30. Available from: http:\/\/dx.doi.org\/10.1007\/s10238-022-00933-x. PubMed Central PMCID: PMC10390598","DOI":"10.1007\/s10238-022-00933-x"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation [Internet]. 2017 Apr 25;135 (17):e927-99. Available from: http:\/\/dx.doi.org\/10.1161\/cir.0000000000000484","DOI":"10.1161\/CIR.0000000000000484"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Masuyama H, Tsuruda T, Sekita Y, et al. Pressure-independent effects of pharmacological stimulation of soluble guanylate cyclase on fibrosis in pressure-overloaded rat heart. Hypertens Res [Internet]. 2009 Jul;32 (7):597-603. Available from: http:\/\/dx.doi.org\/10.1038\/hr.2009.64. PubMed PMID: 19424280","DOI":"10.1038\/hr.2009.64"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Zezina L, Larsson E, Fellstrom B. Candesartan cilexetil reduces graft arteriosclerosis in aortic transplantation model in rat. Transpl Immunol [Internet]. 2001 Feb;8 (4):245-51. Available from: http:\/\/dx.doi.org\/10.1016\/s0966-3274(01)00028-4. PubMed PMID: 11316067","DOI":"10.1016\/S0966-3274(01)00028-4"}],"container-title":["Journal of Nippon Medical School"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/91\/3\/91_JNMS.2024_91-307\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T05:03:16Z","timestamp":1720242196000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/91\/3\/91_JNMS.2024_91-307\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,25]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1272\/jnms.jnms.2024_91-307","relation":{},"ISSN":["1345-4676","1347-3409"],"issn-type":[{"type":"print","value":"1345-4676"},{"type":"electronic","value":"1347-3409"}],"subject":[],"published":{"date-parts":[[2024,6,25]]},"article-number":"JNMS.2024_91-307"}}